Abstract. Spindle cell melanoma (SCM) is a rare morphological subtype of melanoma, which is relatively uncharacterized. The aim of the present study was to investigate the incidence of SCM, its general demographics, basic clinico-pathologic features, treatment outcomes and disease-specific prognostic factors. SCM cases were sampled from the Surveillance, Epidemiology and End Results (SEER) Program (1973Program ( -2017. A total of 4761 SCM cases were identified, with a median age of 66 years. The female:male ratio was 0.62:1. Statistically significant overall survival (OS) and disease-specific survival (DSS) rate differences were identified depending on age, sex, ethnicity, tumor location, T stage, N stage, M stage, pathological grade, AJCC stage, SEER stages and surgical treatment (P<0.05). Multivariate Cox regression analysis revealed that age >66 years, T3+T4 stage disease, positive N stage and SEER historic stage of regional and distant metastasis tumor were associated with poor DSS and OS rates. In summary, SCM was most common in Caucasian people of 60~80 years of age with a predominance in males. Patient's age, ethnicity, T stage, N stage, and SEER historic stage were identified as independent prognostic factors of SCM in terms of DSS and OS.
Introduction
Spindle cell melanoma (SCM) is a rare subtype of malignant melanoma composed of spindled neoplastic cells arranged in sheets and fascicles (1) . The diagnosis of SCM is challenging, as SCM may occur anywhere on the body and frequently mimics amelanotic lesions, including scarring and inflammation (2) (3) (4) . Histologically, cytologic features of SCM are indistinct and often confused with those of other epithelial neoplasms, including sarcomas and lymphomas (5) (6) (7) (8) .
Immunohistochemistry is a helpful tool in distinguishing SCM from other sarcomas and carcinomas (9, 10) . However, diagnosis remains a challenge as a number of sarcomas share some morphological and immunohistochemical features with SCM (5, 11) . Differentiation of SCM from desmoplastic melanoma is difficult because both melanomas are characterized by atypical, spindled, malignant melanocytes. However, the size of spindle cell collagen areas and the immunohistochemical markers, S100, MelanA and Tyrosinase, allow differential diagnosis (10) . Therefore, the integration of clinical and histological assessment is essential for the diagnosis of SCM (2, 8) . Diagnosis of SCM is often delayed until patients exhibit advanced-stage disease, typically with widespread metastasis and poor treatment outcomes (3, 6, 12, 13) .
A limited number of case reports and incomplete retrospective case studies of the differential diagnostic viewpoints of SCM exist (3, 4, (11) (12) (13) (14) (15) . To the best of our knowledge, few studies have reported SCM incidence, clinicopathologic features, treatment, treatment outcome and disease-specific independent prognostic factors. Thus, the present study performed a retrospective analysis of a series of clinical cases using data from the Surveillance, Epidemiology and End Results (SEER) Program.
Materials and methods

Data collection.
In the present study, data was analyzed from the SEER Program, National Cancer Institute Public Use Dataset, which contains publically available records of 18 population-based cancer registries, which together represent 28% of the USA population. Data were extracted regarding patients with a primary diagnosis of SCM, according to the International Classification of Diseases for Oncology, Third Edition (ICD-O-3), using histology codes: 8772/3 (16 was used to analyze associations among baseline parameters. The primary endpoint in the present study was considered to be the date of SCM-associated mortality. The time point between the date of diagnosis and the date of SCM-associated mortality was defined as disease-specific survival (DSS). Mortalities associated with SCM were considered to be events, while deaths attributed to other causes were considered to be 'censored observations'. In terms of overall survival (OS) and DSS rates, Kaplan-Meier method and the log-rank test were utilized and multivariate Cox proportional hazard models were used to identify significant risk factors for survival outcomes. All statistical tests were two-sided, and P<0.05 was considered to indicate a statistically significant difference.
Results
Study population and characteristics.
The following demographic and clinicopathological characteristics were selected for analysis: Age at diagnosis, ethnicity, primary tumor location, Tumor-Node-Metastasis (TNM) stage, American Joint Committee on Cancer (AJCC) stage, pathological grade (the American Joint Committee on Cancer/Union for International Cancer Control staging system), SEER historic stage, treatment modalities, vital status and follow-up time (17) . Unfortunately, complete data was not available for all cases.
Data from 4,761 patient diagnosed with SCM between 1973 and 2017 was retrieved from the SEER database. The total cohort consisted of 1,829 women and 2,932 men, with a female:male ratio of 0.62:1. The patients' age ranged from 3-101 years and a median age of 66 years. The age and sex distributions are presented in Fig. 1 . The median follow-up time was 53 months (range, 0-500 months). Regarding ethnicity, Caucasian people accounted for 96.7% of the study population. The majority of the cases of SCM had originated from the skin, and the eye and bony orbits were the second-most affected tumor site. Surgical resection was performed in 88.7% cases. The basic demographic and clinicopathologic characteristics of the whole patients are summarized in Table I . Kaplan-Meier analysis was utilized for time-to-event analysis. Statistically significant differences in OS rate were identified depending on age (P<0.001), sex (P<0.001), tumor location (P<0.001), ethnicity (P=0.008), AJCC stage (P<0.001), T stage (P<0.001), pathological grade (P<0.001), N stage (P<0.001), treatment modalities (P<0.001) and M stage (P<0.001) (Fig. 2) . Univariate Cox regression analysis analysis revealed that age, ethnicity, sex, tumor location, pathological grade, AJCC stage, T stage, N stage, M stage, SEER historic stage and treatment modalities were associated with OS (Table II) . Multivariate Cox regression analysis revealed that positive N stage, age >66 years and SEER historic stage of regional and distant metastasis were factors independently associated with worse OS (Table III) .
Significant differences in the DSS analysis were also identified depending on age (P<0. (Table II) . The multivariate Cox regression model revealed that age >66 years T3+T4 stage, positive N-stage and SEER historic stage of regional and distant metastasis were independently associated with a poor OS rate (Table III) .
Discussion
As a morphological variant of melanoma, SCM is rare and its incidence has been variably reported between 3 and 14% of all melanoma cases (including desmoplastic melaof all melanoma cases (including desmoplastic mela-(including desmoplastic melanoma) (15, 18, 19) . Diagnosis of SCM is challenging and awareness of its clinical and cytological features as well as immunohistochemical markers are essential to reach the correct diagnosis (9, 10, 15) . Due to the rarity of SCM, its clinical and prognostic characteristics remain to be fully elucidated. To the best of our knowledge, the present study is the first to investigate SCM incidence as well as survival analysis on a large scale.
The present study demonstrates that the incidence of SCM was highest in the 6-8th decade of life in males. Caucasian people accounted for the majority of the study population. SCM lesions originated most commonly from the skin and eyes, and the bony orbits were the second-most affected tumor site. SCM shares various features with conventional melanoma. Previous studies have demonstrated that melanomas arise from the melanocytes of the skin and eyes in response to intrinsic and extrinsic stimuli, including pro-inflammatory signals, oncogenes and UV radiation (12, 20, 21) . Human pigmentation is a polygenic quantitative trait with high heritability and it is modulated by estrogen and androgens via regulation of melanin synthesis (22) . This may explain why SCM mainly Table I . The baseline characteristics of the SCM cases extracted from the SEER database. Table II . Univariate Cox regression analysis in terms of DSS and OS rates of SCM. originates from skin and eyes and has a predilection of male and Caucasian people. According to previous studies, it appears that age, sex, ethnicity and tumor location are important prognostic factors for patients with melanoma (22) (23) (24) . The present study indicates that patients with SCM who were male, aged >66 years, Caucasian, or with tumors located in the skin were associated with poor OS and DSS rates. In the multivariate Cox regression analysis, age >66 years was independently associated with poor OS and DSS rates, which was in consistence with previous studies on melanoma (24) (25) (26) (27) . Seeing as it was demonstrated that SCM was more likely to occur in patients >66 years of age, potential poor tolerance of complications and common comorbidities of elderly patients should be also taken into consideration when making treatment protocol.
DSS OS -------------------------------------------------------------------------------------------------------------------------------------------------------
Pathological grade has been demonstrated to be an important prognostic factor for estimation of survival outcome in melanoma (17) . The results of the present study indicate that well-differentiated SCM was associated with a relatively good outcome both in terms of OS and DSS rate, compared with poorly differentiated SCM. Advanced stage SCM was associated with a relatively poor OS and DSS rates compared with early-stage tumors. Cox multivariate regression also suggested that pathology was an important consideration, with (4, (12) (13) (14) . Metastatic SCM from an unknown primary site should be taken into consideration when diagnosing SCM lesions (15, 18, 28) . Fine-needle aspiration may be a rapid and effective tool for surveillance of recurrent and metastatic cases of SCM, however, accurate diagnosis is challenging owing to the varied cytologic morphologic appearances (6,29-31). In the present study, surgery was the only identified treatment modality for SCM. The results indicate that surgery was favorable for OS and DSS rates. A previous study demonstrated that wide local excision with clear margins, sentinel node biopsy and regular follow-up examinations were crucial in the management of SCM (4) . However, SCM cases should be monitored carefully as metastasis is possible fir multiple years after surgery (32) . For tumors in complex anatomic regions, including the head and neck, the treatment of elderly patients or those at an advanced stage by radical surgery with clear margins is difficult (3) . Under these circumstances, therapeutic planning is challenging (33) . Therefore, multi-cancer randomized clinical trials are urgently required to improve the available treatment for this melanoma subtype.
While the SEER Program is a comprehensive and geographically representative registry, a few limitations of the present study should be noted. Due to alterations of the criteria for the histological diagnosis of SCM the diagnosis of SCM patients in the past may be inconsistent with more recent diagnoses. Another limitation is that complete data was not available for all cases. A number of important prognostic data, including surgical types, margin status and adjuvant therapies were either absent or incomplete in the available SEER data, and therefore there influence on prognosis could not be assessed. In addition, the results suggest that SCM patients may represent an older population, and data on comorbidities that may affect treatment protocols and outcomes is lacking. To the best of our knowledge, this is the first large population study of SCM with a robust long-term follow-up survival assessment provided by SEER, which will improve the existing knowledge of the demographic of SCM, its clinicopathological features and disease-specific prognostic factors.
Overall, a large scale report of SCM demographic trends, clinicopathological features, treatment outcomes and disease-specific independent prognostic factors was presented. The results demonstrate that SCM mostly occurred in Caucasians and males, and the highest incidence occurred in the 6-8th decades of life. Age, ethnicity, T stage, N stage and SEER historic stage were independent prognostic factors of DSS and OS rates.
